Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
• Bevacizumab and Ranibizumab
• Lucentis studies
• Endothelial keratoplast
• Corneal Transplantation
• Ocular research
• Torsional v longtitudinal mode

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Amelia Tope, associate editor.

Click here to contact Neil Hanley, sales manager.
 
OCTOBER 14, 2009
Cancer drug no different in effectiveness as gold standard treatment for macular degeneration
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration. More...
Phase III Lucentis studies show promise for RVO
Two Phase III studies of Lucentis (ranibizumab injection) in macular oedema due to retinal vein occlusion (RVO), have shown, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision. More...
The ongoing evolution of endothelial keratoplast
According to the Review of Ophthalmology refinements in tools and technique are leading to better outcomes, fewer complications and promising new versions of the surgery. More...
Predicted Long-term Outcome of Corneal Transplantation
In Ophthalmology V Borderie et al., analyze graft survival and the outcome of the corneal endothelium after corneal transplantation in a single model to predict the long-term prognosis of these grafts. More...
World’s largest ocular research centre
Real-time biomedical studies of factors leading to vision impairment are now possible through the world's largest ocular research centre at Lions Eye Institute for Transplant & Research. As the first research centre in the world to be directly combined with an eye bank, the Ocular Research Centre provides a repository of healthy and diseased ocular tissue for researchers from academic institutions, government organizations and the pharmaceutical industry. More...
Comparison of torsional and longitudinal modes using phacoemulsification parameters
According to M Rekas et al., in The Journal of Cataract & Refractive Surgery torsional phacoemulsification was found to be more effective than longitudinal phacoemulsification in the amount of applied fluid and the quantity of US energy expended. More...
Coherent Inc. (Santa Clara, CA) (Nasdaq: COHR) has recently expanded its ISO 13485 certification in Europe to include the Excimer laser design and manufacturing facility located in Goettingen, Germany. Read more...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.